Novartis opens manufacturing plant in Maharashtra

July 01, 2022 | Friday | News

The new facility will produce oncology-focused medicines covering both cancer and blood disorders

Sandoz Technical Operations, a Novartis division, has inaugurated its manufacturing plant for medicines and therapies at Kalwe in Mumbai.

 

The plant, which marks a new chapter for Sandoz, will further strengthen the company’s operations in India to support growing healthcare needs globally. The new facility will manufacture oral cancer medicines for the global market and will play a key role in enabling the delivery of high-quality cancer treatment. 

 

The manufacturing facility is spread across 32000 sqm, and houses state-of-the-art production technology. Additionally, built on a brownfield, effluent treatment units installed at the plant shape a next-gen environmentally sustainable manufacturing atmosphere. 

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy